Veru Inc (VERU) Stock Price

2.27 ▼ -0.02 (-0.87%)
Open: 2.30 Vol: 107.5K Day's range: 2.2054 - 2.39 Mar 20, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VERU Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 2.22▲ 2.25▼ 2.27▼ 2.33▼ 2.44▼
MA10 2.24▲ 2.27▼ 2.28▼ 2.39▼ 2.49▼
MA20 2.27▼ 2.31▼ 2.33▼ 2.48▼ 2.45▼
MA50 2.34▼ 2.39▼ 2.41▼ 2.47▼ 2.04▲
MA100 2.40▼ 2.44▼ 2.48▼ 2.50▼ 1.43▲
MA200 2.45▼ 2.50▼ 2.45▼ 2.38▼ 3.06▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.005▼ -0.005▼ -0.028▼ -0.066▼
RSI 43.232▼ 38.575▼ 38.178▼ 38.126▼ 46.482▼
STOCH 15.449▼ 19.890▼ 17.885▼ 11.706▼ 37.901    
WILL %R -54.545     -73.684     -73.684     -86.096▼ -77.027▼
CCI -15.730     -107.692▼ -131.873▼ -135.099▼ -88.281    
Latest Filters Detected On VERU
▼ BREAK $VERU Price Breaks 20 Days Low Set Alert
▼ BREAK $VERU Price Breaks 10 Days Low Set Alert
Veru Inc News
Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Monday, March 09, 2026 07:10 AM
The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients ...
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Monday, March 09, 2026 06:11 AM
The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients ...
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Thursday, February 19, 2026 05:30 AM
MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and ...
VERU historical stock data
date open high low close volume
20/03/26 2.30 2.39 2.2054 2.27 107,499
19/03/26 2.27 2.34 2.22 2.29 52,584
18/03/26 2.37 2.40 2.30 2.30 105,644
17/03/26 2.37 2.47 2.37 2.41 34,046
16/03/26 2.36 2.45 2.36 2.37 37,643
13/03/26 2.46 2.47 2.36 2.39 29,584
12/03/26 2.50 2.5599 2.44 2.46 79,092
11/03/26 2.45 2.55 2.44 2.53 48,377
10/03/26 2.48 2.532 2.4301 2.47 50,036
09/03/26 2.42 2.53 2.4091 2.46 64,406
Quote Details
52wk Low:0.364
52wk High:4.59
Vol:107.5K
Avg Vol(3m):1.7M
1Y Chng:+298.32%
1M Chng:-2.99%
Add to Watch List
More Information
Index US Composite
Market Cap. 36.76M